Niagen Bioscience, Inc.
US ˙ NasdaqCM ˙ US1710774076

SecurityNAGE / Niagen Bioscience, Inc.
InstitutionQuantbot Technologies LP
Latest Disclosed Ownership119,673 shares
Latest Disclosed Value $ 527,758
Quantbot Technologies LP ownership in NAGE / Niagen Bioscience, Inc.

On May 13, 2026 - Quantbot Technologies LP filed a 13F-HR form disclosing ownership of 119,673 shares of Niagen Bioscience, Inc. (US:NAGE) valued at $527,758 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 0 shares of Niagen Bioscience, Inc.. The current value of the position is $411,675 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F NIAGEN BIOSCIENCE COM 171077407 119,673 119,673 528 0.0216
2026-02-10 2025-12-31 13F NIAGEN BIOSCIENCE COM 171077407 0 -5,163 -100.00 0 -100.00
2025-11-12 2025-09-30 13F NIAGEN BIOSCIENCE COM 171077407 5,163 -71,136 -93.23 48 -95.63 0.0013
2025-08-13 2025-06-30 13F NIAGEN BIOSCIENCE COM 171077407 76,299 49,363 183.26 1,099 494.05 0.0282
2025-05-13 2025-03-31 13F NIAGEN BIOSCIENCE COM 171077407 26,936 -2,413 -8.22 186 19.35 0.0059
2025-02-11 2024-12-31 13F CHROMADEX COM 171077407 29,349 29,349 156 0.0057
2022-05-16 2022-03-31 13F CHROMADEX COM 171077407 0 -1,800 -100.00 0 -100.00
2022-02-11 2021-12-31 13F CHROMADEX COM 171077407 1,800 1,100 157.14 6 50.00 0.0005
2021-11-09 2021-09-30 13F CHROMADEX COM 171077407 700 -253 -26.55 4 -55.56 0.0003
2021-08-12 2021-06-30 13F CHROMADEX COM 171077407 953 -757 -44.27 9 -40.00 0.0007
2021-05-14 2021-03-31 13F CHROMADEX COM 171077407 1,710 1,710 79.43 15 66.67 0.0014
2018-05-11 2018-03-31 13F CHROMADEX COM 171077407 0 -500 -100.00 0 -100.00
2018-02-12 2017-12-31 13F CHROMADEX COM 171077407 500 500 2 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.